‘June will be huge’: Avecho boss bullish ahead of CBD trial analysis by Steve Jones March 26, 2026March 26, 2026 Avecho Biotechnology chief executive Paul Gavin has spoken of his belief that the company is on […]
Big pharma makes CBD over-the-counter move as Sandoz strikes 10-year deal with Avecho by Steve Jones March 3, 2025April 29, 2026
Wellnex shelves low dose S3 move amid ‘remote’ chance of registration by Steve Jones June 11, 2024June 11, 2024
Wellnex to launch range of cannabis medicine as more products enter market by Steve Jones June 5, 2024June 6, 2024
OMG announces strategic collaboration for fast-absorption CBD ahead of insomnia trial by Martin Lane April 3, 2024July 16, 2024
Promethean BioPharma joins over-the-counter CBD race by Martin Lane November 30, 2023December 1, 2023
New Zealand reclassifies low-dose CBD, paving the way for OTC sales by Martin Lane October 17, 2023April 30, 2024
Bod Science clinical trial ‘proves the efficacy of CBD’ for pharmacy sales by Steve Jones September 6, 2023September 7, 2023
